Loading...
Loading...
Affymax, Inc.
AFFY and Takeda Pharmaceuticals U.S.A., Inc. (TPUSA)
today announced that the J-code assigned by the Centers for Medicare and
Medicaid Services (CMS) for OMONTYS^® (peginesatide) Injection is now
effective. This permanent OMONTYS-specific billing code, J0890, will continue
to provide for streamlined reimbursement for dialysis organizations
prescribing OMONTYS. OMONTYS is the only once-monthly
erythropoiesis-stimulating agent (ESA) for anemia available to the adult
dialysis patient population with chronic kidney disease (CKD) in the United
States (U.S.).
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in